posted on 2016-05-10, 00:00authored byRD Demissie, P Kabre, ML Tuntland, LW Fung
Triclosan is an effective inhibitor for enoyl acyl carrier protein reductase (ENR) in fatty acid biosynthesis. Triclosan-resistant mutants of ENR have emerged. Thus, it is important to detect these triclosan-resistant mutations in ENR. Generally, enzyme activity assays on the mutants are used to determine the effect of triclosan on ENR activity. Since the substrates are linked to acyl carrier protein (ACP), the assays are challenging due to the need to prepare the ACP and link it to the substrates. Non-ACP-linked (coenzyme A [CoA]-linked) substrates can be used in some ENR, but not in all. Consequently, screening for triclosan-resistant mutants is also challenging. We have developed a simple thermal shift assay, which does not use ACP-linked substrates, to determine the binding ability of triclosan to the ENR active site, and thus it can be used for screening for triclosan-resistant mutants. Staphylococcus aureus FabI enzyme and its mutants were used to demonstrate the binding ability of triclosan with NADP(+) to FabI. The direct correlation between the binding ability and enzyme activity was demonstrated with Francisella tularensis FabI. This method may also be applied to select effective triclosan analogues that inhibit ENR activity.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Proteomics and informatics services were provided by the Chicago Biomedical Consortium (CBC)—UIC Research Resources Center Mass Spectrometry, Metabolomics and Proteomics Facility, which was established in part by a grant from the Searle Funds at the Chicago Community Trust to the CBC. R.D.D. is an awardee of the Bridge to the Doctorate Fellowship at UIC. The work was supported by a grant from the National Institutes of Health (U01 AI-077949).
History
Publisher Statement
This is the author’s version of a work that was accepted for publication in Journal of Biomolecular Screening. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Biomolecular Screening, 2016, 21(4): 391-398. DOI: 10.1177/1087057115615085.